{"transactions":[{"id":2637999,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-08T21:19:29.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/24th of the total number of shares subject to the option in successive, equal monthly installments measured from July 6, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":13.63,"expiration_date":"2031-07-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001567619-21-013149","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921013149/doc1.xml","form_type":"4"}},{"id":2637998,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:19:29.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on July 6 of each year, with the first 1/2 vesting on July 6, 2022 and with the RSUs being fully vested on July 6, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 122,083 RSUs and 1,388 shares of Common Stock purchased under Issuer's Employee Stock Purchase Plan on May 14, 2021 in a transaction exempt from Section 16(b) under Rule 16b3(c)."}],"balance_after":124790,"source":{"system":"sec-edgar","filing":"0001567619-21-013149","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921013149/doc1.xml","form_type":"4"}},{"id":2734280,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-30T20:39:12.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on April 1 of each year, with the first 1/2 vesting on April 1, 2022 and with the RSUs being fully vested on April 1, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 72,083 RSUs."}],"balance_after":73402,"source":{"system":"sec-edgar","filing":"0001567619-21-008805","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921008805/doc1.xml","form_type":"4"}},{"id":2799059,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-09T21:24:02.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":20312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 15, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":4688,"derivative":{"exercise_price":9.3,"expiration_date":"2027-11-15","underlying":"Common Stock","underlying_shares":20312},"source":{"system":"sec-edgar","filing":"0001567619-21-005917","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921005917/doc1.xml","form_type":"4"}},{"id":2799058,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-09T21:24:02.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":6337,"price":15.46,"value":97970.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":53402,"source":{"system":"sec-edgar","filing":"0001567619-21-005917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921005917/doc1.xml","form_type":"4"}},{"id":2799057,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-09T21:24:02.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":20312,"price":15.4635,"value":314094.612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.45 to $15.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":59739,"source":{"system":"sec-edgar","filing":"0001567619-21-005917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921005917/doc1.xml","form_type":"4"}},{"id":2799056,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-09T21:24:02.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":20312,"price":9.3,"value":188901.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":80051,"source":{"system":"sec-edgar","filing":"0001567619-21-005917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921005917/doc1.xml","form_type":"4"}},{"id":2845620,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:11:59.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":2488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2488},"source":{"system":"sec-edgar","filing":"0001567619-21-004508","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921004508/doc1.xml","form_type":"4"}},{"id":2845619,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:11:59.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":2488,"price":17.4511,"value":43418.3368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $17.19 to $17.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":59739,"source":{"system":"sec-edgar","filing":"0001567619-21-004508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921004508/doc1.xml","form_type":"4"}},{"id":2845618,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:11:59.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":2488,"price":2.5005,"value":6221.244,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":62227,"source":{"system":"sec-edgar","filing":"0001567619-21-004508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921004508/doc1.xml","form_type":"4"}},{"id":2900390,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T21:22:02.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":2488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-21-001335","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921001335/doc1.xml","form_type":"4"}},{"id":2900389,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:22:02.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":2500,"price":17.9408,"value":44852.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $17.76 to $18.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":59739,"source":{"system":"sec-edgar","filing":"0001567619-21-001335","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921001335/doc1.xml","form_type":"4"}},{"id":2900388,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:22:02.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":62239,"source":{"system":"sec-edgar","filing":"0001567619-21-001335","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921001335/doc1.xml","form_type":"4"}},{"id":2907964,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T21:22:21.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-21-000981","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921000981/doc1.xml","form_type":"4"}},{"id":2907963,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-13T21:22:21.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 RSUs."}],"balance_after":59739,"source":{"system":"sec-edgar","filing":"0001567619-21-000981","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921000981/doc1.xml","form_type":"4"}},{"id":2909306,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-12T21:53:32.000Z","date":"2021-01-10","kind":"tax_withholding","acquired":false,"shares":4080,"price":18.18,"value":74174.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,833 restricted stock units."}],"balance_after":28489,"source":{"system":"sec-edgar","filing":"0001567619-21-000921","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761921000921/doc1.xml","form_type":"4"}},{"id":2935853,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-21T21:10:54.000Z","date":"2020-12-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":4988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-021405","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920021405/doc1.xml","form_type":"4"}},{"id":2935852,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-21T21:10:54.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":2500,"price":17.512,"value":43780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $17.41 to $17.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-021405","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920021405/doc1.xml","form_type":"4"}},{"id":2935851,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-21T21:10:54.000Z","date":"2020-12-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":35069,"source":{"system":"sec-edgar","filing":"0001567619-20-021405","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920021405/doc1.xml","form_type":"4"}},{"id":2951302,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T22:53:25.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":5791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":5791},"source":{"system":"sec-edgar","filing":"0001567619-20-020818","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020818/doc1.xml","form_type":"4"}},{"id":2951301,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T22:53:25.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":123000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-20-020818","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020818/doc1.xml","form_type":"4"}},{"id":2951300,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-09T22:53:25.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":8791,"price":18.4161,"value":161895.9351,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $18.30 to $18.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-020818","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020818/doc1.xml","form_type":"4"}},{"id":2951299,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-09T22:53:25.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":5791,"price":12.7,"value":73545.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":41360,"source":{"system":"sec-edgar","filing":"0001567619-20-020818","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020818/doc1.xml","form_type":"4"}},{"id":2951298,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-09T22:53:25.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":3000,"price":12.37,"value":37110.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":35569,"source":{"system":"sec-edgar","filing":"0001567619-20-020818","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020818/doc1.xml","form_type":"4"}},{"id":2954861,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":16709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":5791,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":16709},"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954860,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":32291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from May 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":17709,"derivative":{"exercise_price":16.75,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":32291},"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954859,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 10, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":49480,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954858,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":36736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":17.17,"expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":36736},"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954857,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":49000,"price":18.8509,"value":923694.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $18.565 to $19.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954856,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":16709,"price":12.7,"value":212204.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":81569,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954855,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":32291,"price":16.75,"value":540874.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":64860,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954854,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":49756,"price":18.6727,"value":929078.8612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $18.58 to $18.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954853,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":13020,"price":17.73,"value":230844.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":82325,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2954852,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:51:33.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":36736,"price":17.17,"value":630757.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":69305,"source":{"system":"sec-edgar","filing":"0001567619-20-020705","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020705/doc1.xml","form_type":"4"}},{"id":2972792,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-18","kind":"exercise","acquired":false,"shares":4283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":22500,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":4283},"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972791,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":7488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972790,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":4283,"price":18,"value":77094.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972789,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-18","kind":"exercise","acquired":true,"shares":4283,"price":12.7,"value":54394.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":36852,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972788,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":3567,"price":17.677,"value":63053.859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $17.46 to $17.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":32569,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972787,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":12420,"price":17.6827,"value":219619.134,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $17.44 to $17.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":36136,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972786,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":2500,"price":17.4974,"value":43743.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $17.27 to $17.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":2972785,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-19T21:16:59.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-020096","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920020096/doc1.xml","form_type":"4"}},{"id":3001971,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T20:04:48.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":26783,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001567619-20-018056","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/doc1.xml","form_type":"4"}},{"id":3001970,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T20:04:48.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":9988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-018056","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/doc1.xml","form_type":"4"}},{"id":3001969,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-10-21T20:04:48.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":3217,"price":17.8911,"value":57555.6687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $17.53 to $18.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-018056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/doc1.xml","form_type":"4"}},{"id":3001968,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-10-21T20:04:48.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":717,"price":12.7,"value":9105.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51773,"source":{"system":"sec-edgar","filing":"0001567619-20-018056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/doc1.xml","form_type":"4"}},{"id":3001967,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-10-21T20:04:48.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-018056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/doc1.xml","form_type":"4"}},{"id":3025768,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-21T21:06:31.000Z","date":"2020-09-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":27500,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-016945","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/doc1.xml","form_type":"4"}},{"id":3025767,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-21T21:06:31.000Z","date":"2020-09-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":12488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-016945","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/doc1.xml","form_type":"4"}},{"id":3025766,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-21T21:06:31.000Z","date":"2020-09-17","kind":"sale","acquired":false,"shares":5000,"price":18.8432,"value":94216.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $18.58 to $19.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-016945","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/doc1.xml","form_type":"4"}},{"id":3025765,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-21T21:06:31.000Z","date":"2020-09-17","kind":"exercise","acquired":true,"shares":2500,"price":12.7,"value":31750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":53556,"source":{"system":"sec-edgar","filing":"0001567619-20-016945","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/doc1.xml","form_type":"4"}},{"id":3025764,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-09-21T21:06:31.000Z","date":"2020-09-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-016945","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/doc1.xml","form_type":"4"}},{"id":3051954,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-19T20:23:21.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":30000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-015756","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/doc1.xml","form_type":"4"}},{"id":3051953,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-19T20:23:21.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":14988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-015756","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/doc1.xml","form_type":"4"}},{"id":3051952,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-19T20:23:21.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":5000,"price":19.3702,"value":96851.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $19.08 to $19.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-015756","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/doc1.xml","form_type":"4"}},{"id":3051951,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-19T20:23:21.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":2500,"price":12.7,"value":31750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":53556,"source":{"system":"sec-edgar","filing":"0001567619-20-015756","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/doc1.xml","form_type":"4"}},{"id":3051950,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-19T20:23:21.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-015756","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/doc1.xml","form_type":"4"}},{"id":3078580,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-21T21:04:49.000Z","date":"2020-07-17","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":32500,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001567619-20-013539","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/doc1.xml","form_type":"4"}},{"id":3078579,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-21T21:04:49.000Z","date":"2020-07-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":17488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-013539","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/doc1.xml","form_type":"4"}},{"id":3078578,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-21T21:04:49.000Z","date":"2020-07-17","kind":"sale","acquired":false,"shares":15000,"price":18.2458,"value":273687.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $18.11 to $18.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-013539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/doc1.xml","form_type":"4"}},{"id":3078577,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-21T21:04:49.000Z","date":"2020-07-17","kind":"exercise","acquired":true,"shares":12500,"price":12.7,"value":158750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":63556,"source":{"system":"sec-edgar","filing":"0001567619-20-013539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/doc1.xml","form_type":"4"}},{"id":3078576,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-21T21:04:49.000Z","date":"2020-07-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-013539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/doc1.xml","form_type":"4"}},{"id":3104023,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:35:13.000Z","date":"2020-06-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":19988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-012458","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/doc1.xml","form_type":"4"}},{"id":3104022,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-06-19T20:35:13.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":2500,"price":17.22,"value":43050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-012458","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/doc1.xml","form_type":"4"}},{"id":3104021,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-06-19T20:35:13.000Z","date":"2020-06-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-012458","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/doc1.xml","form_type":"4"}},{"id":3140474,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T21:01:19.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":22488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-010834","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/doc1.xml","form_type":"4"}},{"id":3140473,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-05-20T21:01:19.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":2500,"price":17.17,"value":42925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,303 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-010834","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/doc1.xml","form_type":"4"}},{"id":3140472,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-05-20T21:01:19.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,303 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":51056,"source":{"system":"sec-edgar","filing":"0001567619-20-010834","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/doc1.xml","form_type":"4"}},{"id":3140471,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-05-20T21:01:19.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":593,"price":17.17,"value":10181.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,303 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001567619-20-010834","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/doc1.xml","form_type":"4"}},{"id":3172211,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-21T20:24:53.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":24988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-20-008227","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/doc1.xml","form_type":"4"}},{"id":3172210,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-21T20:24:53.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":5150,"price":17,"value":87550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":47846,"source":{"system":"sec-edgar","filing":"0001567619-20-008227","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/doc1.xml","form_type":"4"}},{"id":3172209,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-21T20:24:53.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":5000,"price":15.57,"value":77850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":52996,"source":{"system":"sec-edgar","filing":"0001567619-20-008227","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/doc1.xml","form_type":"4"}},{"id":3172208,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-21T20:24:53.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":5000,"price":2.5005,"value":12502.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":57996,"source":{"system":"sec-edgar","filing":"0001567619-20-008227","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/doc1.xml","form_type":"4"}},{"id":3258922,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":45000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258921,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":29988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258920,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":5000,"price":21.638,"value":108190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $21.453 to $21.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":52996,"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258919,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":2500,"price":21.64,"value":54100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":57996,"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258918,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":2500,"price":12.7,"value":31750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":60496,"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258917,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":2500,"price":21.64,"value":54100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":57996,"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3258916,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-20T21:07:42.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":60496,"source":{"system":"sec-edgar","filing":"0001567619-20-004436","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/doc1.xml","form_type":"4"}},{"id":3305096,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":47500,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305095,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":32488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305094,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":2500,"price":19.6853,"value":49213.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $19.46 to $19.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":57996,"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305093,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":2500,"price":12.7,"value":31750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":60496,"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305092,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":5000,"price":19.5592,"value":97796.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $19.35 to $19.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":57996,"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305091,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":2500,"price":19.5685,"value":48921.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $19.34 to $19.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":62996,"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3305090,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-22T21:06:01.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":65496,"source":{"system":"sec-edgar","filing":"0001567619-20-001353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/doc1.xml","form_type":"4"}},{"id":3311421,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T22:48:23.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 10, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-20-001038","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/doc1.xml","form_type":"4"}},{"id":3311420,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T22:48:23.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 10 of each year, with the first 1/3 vesting on January 10, 2021 and with the RSUs being fully vested on January 10, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 RSUs."}],"balance_after":62996,"source":{"system":"sec-edgar","filing":"0001567619-20-001038","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/doc1.xml","form_type":"4"}},{"id":3311419,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T22:48:23.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":7146,"price":17.73,"value":126698.58,"ownership":{"direct":true},"balance_after":31746,"source":{"system":"sec-edgar","filing":"0001567619-20-001038","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/doc1.xml","form_type":"4"}},{"id":3311418,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T22:48:23.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":19566,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38892,"source":{"system":"sec-edgar","filing":"0001567619-20-001038","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/doc1.xml","form_type":"4"}},{"id":3336355,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-18T21:28:01.000Z","date":"2019-12-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":34988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-19-023319","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/doc1.xml","form_type":"4"}},{"id":3336354,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-12-18T21:28:01.000Z","date":"2019-12-16","kind":"sale","acquired":false,"shares":2500,"price":18.69,"value":46725.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16 shares acquired on November 15, 2019, pursuant to Issuer's employee stock purchase plan."}],"balance_after":19326,"source":{"system":"sec-edgar","filing":"0001567619-19-023319","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/doc1.xml","form_type":"4"}},{"id":3336353,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-12-18T21:28:01.000Z","date":"2019-12-16","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16 shares acquired on November 15, 2019, pursuant to Issuer's employee stock purchase plan."}],"balance_after":21826,"source":{"system":"sec-edgar","filing":"0001567619-19-023319","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/doc1.xml","form_type":"4"}},{"id":3367830,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T21:10:43.000Z","date":"2019-11-14","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":37488,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-19-021759","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/doc1.xml","form_type":"4"}},{"id":3367829,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-18T21:10:43.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":2500,"price":19.26,"value":48150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."}],"balance_after":19310,"source":{"system":"sec-edgar","filing":"0001567619-19-021759","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/doc1.xml","form_type":"4"}},{"id":3367828,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-18T21:10:43.000Z","date":"2019-11-14","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"balance_after":21810,"source":{"system":"sec-edgar","filing":"0001567619-19-021759","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/doc1.xml","form_type":"4"}},{"id":3392726,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-16T20:08:09.000Z","date":"2019-10-14","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":39988,"derivative":{"exercise_price":2.5005,"expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-19-025608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/doc4.xml","form_type":"4"}},{"id":3392725,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-10-16T20:08:09.000Z","date":"2019-10-14","kind":"sale","acquired":false,"shares":2500,"price":18.4,"value":46000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."}],"balance_after":19310,"source":{"system":"sec-edgar","filing":"0000899243-19-025608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/doc4.xml","form_type":"4"}},{"id":3392724,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":137473,"kind":"person","name":"Anicetti Vincent R","position":1,"cik":"0001733375","reported_name":"Anicetti Vincent R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-10-16T20:08:09.000Z","date":"2019-10-14","kind":"exercise","acquired":true,"shares":2500,"price":2.5005,"value":6251.25,"ownership":{"direct":true},"balance_after":21810,"source":{"system":"sec-edgar","filing":"0000899243-19-025608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/doc4.xml","form_type":"4"}}],"next_cursor":"2019-10-16T20:08:09.000000Z,3392724"}